University Department of Anaesthesia, Nottingham City Hospital, Nottingham NG5 1PB, UK *Corresponding author: University Department of Anaesthesia and Critical Care, Queens Medical Centre, Nottingham NG7 2UH, UK
Accepted for publication: June 24, 2002
![]() |
Abstract |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Methods. Thirty patients with pre-eclampsia were recruited. Age- and height-matched healthy pregnant (n=30) and non-pregnant control (n=30) groups were also recruited. Monitoring included transcranial Doppler ultrasonography, end-tidal carbon dioxide and non-invasive arterial pressure measurement. Cerebral autoregulation was assessed by performing the transient hyperaemic response (THR) test. The cerebrovascular reactivity to carbon dioxide (CRCO2) was assessed by measuring middle cerebral artery blood flow velocity (MCAFV) after induced changes in end-tidal carbon dioxide. Estimated cerebral perfusion pressure (eCPP) and critical closing pressure (CrCP) were calculated using established formulae. Statistical analysis included ANOVA with Tukeys pairwise comparisons.
Results. Mean arterial pressure (MAP) was increased in pre-eclampsia (P<0.05). Mean MCAFV was lower in healthy pregnancy (P<0.05), but in pre-eclampsia it was similar to the non- pregnant group. When compared with the non-pregnant group, mean eCPP was higher in the healthy pregnant and pre-eclamptic groups (P<0.05). There were no meaningful differences in cerebral autoregulation or CRCO2.
Conclusions. Healthy pregnancy increases eCPP, presumably by decreasing CrCP. In pre-eclampsia, eCPP is maintained at the same level as in healthy pregnancy despite an increased MAP. Pre-eclampsia has no significant effect on cerebral autoregulation or CRCO2.
Br J Anaesth 2002; 89: 68792
Keywords: complications, pre-eclampsia; measurement techniques, Doppler ultrasound; brain, blood flow; cardiovascular system, effects
![]() |
Introduction |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Non-invasive assessment of cerebral haemodynamics using TCD ultrasonography has recently gained importance. Essentially, TCD measures flow velocity in the insonated vessel and the changes in flow velocity can be taken to reflect the changes in blood flow, assuming that the diameter of the insonated vessel remains constant. As TCD is easy to use and gives reproducible measurements, it has become a widely accepted method of assessing the cerebrovascular reactivity to carbon dioxide (CRCO2), cerebral autoregulation, estimated (e)CPP, and CrCP.7 915 In patients with neurological disorders, impairment in both cerebral autoregulation and cerebral vascular reactivity has been shown to predict poor neurological outcome.1517 Knowledge of the effects of normal pregnancy and pre-eclampsia on cerebral haemodynamics is essential for appropriate management of these patients undergoing anaesthesia or in labour, particularly when vasoactive medications are administered.
The aim of the present study was to make a comparative assessment of cerebral haemodynamic variables such as cerebral autoregulation, CRCO2, eCPP, and CrCP, using TCD in pre-eclamptic patients, healthy pregnant women, and healthy non-pregnant women.
![]() |
Materials and methods |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Assessment of cerebrovascular haemodynamics was performed as soon as possible after the diagnosis of pre-eclampsia. Patients age, height, body mass index (BMI), gestational age (in pregnant patients), and arterial pressure were recorded. Before recruitment into the study, all the patients were fully assessed by obstetricians and those with severe pre-eclampsia (diastolic arterial pressure greater than 110 mm Hg and/or evidence of hyper-reflexia) were admitted immediately for anti-hypertensive therapy and/or induction of labour, and could not therefore be included in the study. The pre-eclamptic patients who were admitted to the study underwent carotid ultrasound scan to exclude any significant carotid artery disease.
All pre-eclamptic subjects were followed-up at 6 and/or 12 weeks post-partum to ensure that their arterial pressure had returned to normal levels, proteinuria had cleared, and that they had not suffered any neurological problems at any time during their stay in hospital or thereafter.
Study set-up
All subjects were studied in the supine position. The pregnant women were positioned with 15° left-lateral tilt to minimize any aortocaval compression. The left middle carotid artery (MCA) was identified using a 2 MHz-pulsed TCD probe (SciMed PCDop 842), and the position of the probe was fixed with a headband to ensure a constant angle of insonation throughout the period of the study. TCD measurements were recorded onto digital audiotape for subsequent analysis using specific software (SciMed UK). Following application of a nose clip, constant end-tidal carbon dioxide (E'CO2) monitoring was instituted via a mouthpiece connected to a Datex Capnomac monitor. The arterial pressure was measured at 1-min intervals with a non-invasive arterial pressure monitor (Dynamap) for the duration of the test. Further monitoring included heart rate and oxygen saturation measurements using pulse oximetry.
Following a period of acclimatization to the study apparatus, each subjects baseline heart rate, arterial pressure, oxygen saturation, E'CO2, and MCAFV were recorded.
TCD data
Cerebral autoregulation was assessed by the transient hyperaemic response (THR) test.12 13 This involved a 10-s compression of the ipsilateral common carotid artery (CCA) followed by sudden release of the compression, leading to hyperaemic flow in the MCA. Criteria for acceptance of a THR test were: (1) a sudden and maximal decrease in flow velocity at onset of the compression; (2) stable heart rate for the period of the compression; (3) steady TCD signal for the duration of the compression; and (4) absence of flow transients following release of the compression.
Two indices were used to analyse the THR test to assess autoregulation: the transient hyperaemic response ratio (THRR);11 and the strength of autoregulation (SA).12 13 To calculate these indices, three MCAFV waveforms were selected from the recordings during the THR test (Fig. 1): (1) the MCA waveform immediately before compression, F1; (2) the first waveform following compression, F2; and (3) the waveform immediately following release of compression, F3. The time-averaged mean of the outer envelope of the flow velocity profile was used for performing the analysis (Fig. 1). THRR was calculated as:11
|
SA was calculated as:13
SA=(F3xP2)/(MAPxF1)
where P2 is the greater value of either the estimated arterial pressure in the MCA at the onset of CCA compression, as calculated by P2=MAPxF2/F1, or 60 mm Hg (the assumed lower limit of autoregulation). Details of the derivation of these formulae have been published elswhere.12 13
The compression ratio (CR), a measure of the magnitude of decrease in flow velocity during the compression, was calculated using the formula:11
CR%=(F1F2)x(100/F1)
CRCO2 was assessed by recording the MCAFV during induced hypocapnia (voluntary hyperventilation to an E'CO2 of 1 kPa below baseline), and hypercapnia (addition of carbon dioxide to the inspired gases (oxygen-enriched air) to achieve an E'CO2 of 1 kPa above baseline). CRCO2 was calculated as per cent change in MCAFV per kPa change in E'CO2.
The eCPP and CrCP were calculated using the method described by Belfort and colleagues.7
CrCP=MAP eCPP
Statistics
We calculated that 30 patients would be required in each of the three groups to detect a 20% difference in the SA across the groups with 90% power at alpha=0.05, assuming the coefficient of variation of SA to be approximately 10%. The coefficient of variation for SA was assumed because of lack of previous data in pregnant women.
All data sets were checked for normality of distribution using the AndersonDarling test. For comparisons between groups, ANOVA with Tukeys test (for pairwise comparison) was used for parametric data, and KruskalWallis test was used for non-parametric data. P<0.05 was used to denote statistical significance. Minitab Release 13.3 was used for all statistical analyses.
![]() |
Results |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
The characteristics of the three groups of women included in the study are shown in Table 1. The groups were comparable for distribution of age and height; parity and gestation in healthy pregnant patients were similar to pre-eclamptics. Compared with non-pregnant subjects, the BMI in pre-eclamptic patients was significantly higher (P<0.05).
|
|
|
![]() |
Discussion |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Changes in MCAFV
The effects of pregnancy and/or pre-eclampsia on MCAFV have been studied by other investigators. Ikeda and colleagues3 5 found little change in mean MCAFV during the first two trimesters but reduced values in the third trimester. Williams and Wilson4 showed that MCAFV fell significantly with advancing gestational age. In another study, Williams and Wilson18 used TCD to assess cerebral haemodynamics in 17 non-pregnant women, 17 normotensive pregnant women, 20 pregnant women with pre-existing hypertension, and 21 pre-eclamptic women. The pregnant women were all in their third trimester. There was no difference in mean MCAFV in healthy pregnancy compared with non-pregnant women and a small, but non-significant, increase in mean MCAFV in the hypertensive and pre-eclamptic women. Demarin and colleagues6 studied pre-eclamptic women before and after delivery and found a progressive increase in MCAFV during late pregnancy. Ohno and colleagues19 compared MCAFV in 35 healthy pregnant and 17 pre-eclamptic women. In this study, the mean MCAFV was significantly higher in the pre-eclamptic group. It has been suggested that these increases in MCAFV are because of a degree of vasospasm. The differences between the findings of various studies with regards to the changes in MCAFV in pre-eclampsia might be explained by the differences in the severity of pre-eclampsia between the studies. Some investigators have reported increased MCAFV in symptomatic, compared with asymptomatic pre-eclamptics.6 20 21
In the present study, all our patients in the pre-eclampsia group were asymptomatic. We found that the values of MCAFV in pre-eclampsia, although similar to those in the non-pregnant group, were significantly higher than those seen in healthy pregnancy. These findings are in agreement with some of the previous reports.3 5 6 19 Overall, it would appear that MCAFV falls with advancing gestational age. An increase in late pregnancy to a level equal to, or greater than, normal non-pregnant velocities is suggestive of pre-eclampsia and probable underlying vasospasm.
Cerebral autoregulation and carbon dioxide reactivity
As far as we are aware, there are no previously reported studies using TCD, which have looked specifically at the effects of pregnancy and/or pre-eclampsia upon cerebral autoregulation or CRCO2. It has been generally assumed that cerebral autoregulation remains intact during healthy pregnancy as the increase in cerebral blood flow is limited despite the raised cardiac output.1 With respect to pre-eclampsia, some investigators have suggested that the endothelial dysfunction seen in the pre-eclampsia/eclampsia syndrome may alter cerebral haemodynamics.22
Our study confirms that cerebral autoregulation remains intact in healthy pregnancy, as we found no significant differences in THRR, SA, or CRCO2 between the non-pregnant and healthy pregnant groups. In addition, perhaps surprisingly, we found no difference in these variables in patients with pre-eclampsia. This may be because all our pre-eclamptic patients were asymptomatic, and therefore, can be supposed to have had only mild disease. None of the pre-eclamptic women we studied went on to suffer an eclamptic seizure. Our study procedure required a carotid ultrasound scan in the department of radiology before investigation of the patients cerebral haemodynamics. We were therefore unable to investigate severe pre-eclamptics as they were either confined to the labour suite, or underwent urgent Caesarean section. The carotid ultrasound scan in pre-eclamptic patients was performed to rule out the presence of any atheromatous plaques in the internal carotid artery, which in theory, could be dislodged during carotid compression for the THR test. The risk of developing atheromatous disease in pre-eclampsia has not been reported. We decided to screen pre-eclamptic patients as a matter of precaution because hypertension is one of the risk factors for developing atheromatous disease. Patients from other groups were not screened because they did not have any of the risk factors associated with atheromatous disease.
CPP and CrCP
Some studies have investigated eCPP in pre-eclamptic patients. Williams and Wilson18 found that mean eCPP was significantly lower in non-pregnant women compared with both healthy pregnant and (mild) pre-eclamptic women. Belfort and colleagues22 suggested that the brain can be normally perfused, under-perfused or over-perfused in pre-eclampsia. In a different study, Belfort and colleagues20 also found that increasing severity of headache was associated with increasing eCPP.
We found a lower eCPP in non-pregnant women compared with healthy pregnant and pre-eclamptic women. There was no difference between healthy pregnancy and pre-eclampsia. These findings are similar to those of Williams and Wilson,18 although the absolute values of eCPP in our study are different. Previously reported results by Belfort and colleagues,20 would suggest that the majority of the pre-eclamptics in our study had mild disease. The interpretation of the results of our study in conjunction with the previous studies, 18 2022 would suggest that pregnancy leads to an increase in eCPP, with further increases in symptomatic, but not severe pre-eclampsia.
The only previously published data on cerebral CrCP in pregnancy comes from Belfort and colleagues7 in a study of the effects of nimodipine and magnesium on eCPP in pre-eclampsia. They found that magnesium increased, and nimodipine reduced CrCP. Our data suggest that CrCP is reduced in the latter stages of healthy pregnancy, compared with non-pregnant women. This results in increased eCPP in healthy pregnancy despite an unchanged MAP. However, in pre-eclampsia the CrCP increases, probably as a result of increased vascular tone, so that despite a significant increase in MAP, the level of eCPP remains unchanged.
What is the clinical significance of our results? As cerebral autoregulation and CRCO2 are preserved in healthy pregnancy and in asymptomatic pre-eclampsia, these groups of patients should be able to tolerate moderate changes in E'CO2 or MAP under anaesthesia. Healthy pregnancy is associated with increased eCPP, which is a result of a decrease in downstream CrCP. In pre-eclampsia, an increase in MAP is also associated with an increase in downstream pressure, therefore CPP is maintained. The hypotensive agents used in pre-eclampsia may affect CrCP in varying manner. It would be logical to use agents that affect MAP and CrCP in a similar fashion so the CPP is maintained. Therapies that reduce MAP but not CrCP will reduce cerebral perfusion. Further work needs to be done in this field, both to study the effects of severe/symptomatic pre-eclampsia upon the cerebral circulation, and the effects of the various anti-hypertensive drugs used in its treatment.
![]() |
Acknowledgement |
---|
![]() |
References |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
2 Kim TH, Weiner CP, Thompson LP. The effect of pregnancy on contraction and endothelium-mediated relaxation of renal and mesenteric arteries. Am J Physiol 1994; 267: 417
3 Ikeda T, Ikenoue T, Mori N, et al. Effect of early pregnancy on maternal regional cerebral blood flow. Am J Obstet Gynecol 1993; 168: 13038[ISI][Medline]
4 Williams K, Wilson S. Maternal middle cerebral artery blood flow velocity variation with gestational age. Obstet Gynecol 1994; 84: 4458[Abstract]
5 Ikeda T, Mori N. Assessment of cerebral haemodynamics in pregnant women by internal carotid artery pulsed Doppler velocimetry. Am J Obstet Gynecol 1990; 163: 4948[ISI][Medline]
6 Demarin V, Rundek T, Hodek B. Maternal cerebral circulation in normal and abnormal pregnancies. Acta Obstet Gynecol Scand 1997; 76: 61924[ISI][Medline]
7 Belfort MA, Saade GR, Yared M, et al. Change in estimated cerebral perfusion pressure after treatment with nimodipine or magnesium sulphate in patients with preeclampsia. Am J Obstet Gynecol 1999; 181: 4027[ISI][Medline]
8 Ramanathan J, Angel JJ, Bush AJ, Lawson P, Sibai B. Changes in maternal cerebral artery blood flow velocity associated with general anaesthesia in severe preeclampsia. Anesth Analg 1999; 88: 35762
9 Matta BF, Lam AM, Strebel S, Mayberg TS. Cerebral pressure autoregulation and carbon dioxide reactivity during propofol-induced EEG suppression. Br J Anaesth 1995; 74: 15973
10 Giller CA. A bedside test for cerebral autoregulation using transcranial Doppler ultrasound. Acta Neurochir 1991; 108: 714[ISI]
11 Smielewski P, Czosnyka M, Kirkpatrick P, McEroy H, Rutkowska H, Pickard JD. Assessment of cerebral autoregulation using carotid artery compression. Stroke 1996; 27: 2197203
12 Mahajan RP, Cavill G, Simpson EJ, Hope DT. In Klingelhofer J (ed.) New Trends in Cerebral Haemodynamics and Neurosonology. Amsterdam: Elsevier Science BV, 1997; 61823
13 Mahajan RP, Cavill G, Simpson EJ. Reliability of the transient hyperemic response test in detecting changes in cerebral autoregulation induced by the graded variations in end-tidal carbon dioxide. Anesth Analg 1998; 87: 8439[Abstract]
14 Czosnyka M, Smielewski P, Piechnik S, et al. Critical closing pressure in cerebrovascular circulation. J Neurol Neurosurg Psychiatry 1999; 66: 60611
15 Dernbach PD, Little JR, Jones SC, Ebrahim ZY. Altered cerebral autoregulation and CO2 reactivity after aneurysmal subarachnoid hemorrhage. Neurosurgery 1988; 22: 8226[ISI][Medline]
16 Lovick AH, Pickard JD, Goddard BA. Prediction of late ischaemic complications after cerebral aneurysm surgeryuse of a mobile microcomputer system for the measurement of pre-, intra- and postoperative cerebral blood flow. Acta Neurochir 1982; 63: 3742[ISI]
17 Pickard JD, Matheson M, Patterson J, Wyper D. Prediction of late ischemic complications after cerebral aneurysm surgery by the intraoperative measurement of cerebral blood flow. J Neurosurg 1980; 53: 3058[ISI][Medline]
18 Williams KP, Wilson S. Variation in cerebral perfusion pressure with different hypertensive states in pregnancy. Am J Obstet Gynecol 1998; 179: 12003[ISI][Medline]
19 Ohno Y, Kawai M, Wakahara Y, Kitagawa T, Kakihara M, Arii Y. Transcranial assessment of maternal cerebral blood flow velocity in patients with pre-eclampsia. Acta Obstet Gynecol Scand 1997; 76: 92832[ISI][Medline]
20 Belfort MA, Saade GR, Grunewald C, et al. Association of cerebral perfusion pressure with headache in women with pre-eclampsia. Br J Obstet Gynaecol 1999; 106: 81421[ISI][Medline]
21 Zunker P, Ley-Pozo J, Louwen F, Schuierer G, Holzgreve W, Ringelstein EB. Cerebral haemodynamics in pre-eclampsia/eclampsia syndrome. Ultrasound Obstet Gynecol 1995; 6: 4115[ISI][Medline]
22 Belfort MA, Grunewald C, Saade GR, Varner M, Nisell H. Preeclampsia may cause both overperfusion and underperfusion of the brain: a cerebral perfusion based model. Acta Obstet Gynecol Scand 1999; 78: 58691[ISI][Medline]